GL1X · GenesisL1 explorer

Research workbench

Fragment based P38 inhibitors

Analyse Fragment based P38 inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1WBN
Type
protein
Length
351 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 14
EC
2.7.1.37
UniProt
Q16539
Ligands
L09
Pockets
4 · best druggability 0.77

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 14 (EC 2.7.1.37)protein35140% helix, 15% strandQ16539

Ligands and binding sites

  • L09 · N-(3-tert-butyl-1H-pyrazol-5-yl)-N'-{4-chloro-3-[(pyridin-3-yloxy)methyl]phenyl}urea · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16850.770.8260L09
22680.550.7642empty
3780.320.7420empty
4610.310.7516empty

Compared structures

  • 1WBN · fragment based p38 inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.